
Overview
Marco Dal Molin, M.D., is a surgical oncologist that specializes in hepatobiliary, pancreatic and gastrointestinal surgical oncology at the Johns Hopkins Hospital. Dr. Dal Molin earned his medical degree at the University of Verona School of Medicine in Italy, followed by a general surgery residency at the University of Verona/Pancreas Institute. He completed a second general surgery residency at the University of Maryland in Baltimore, and a fellowship in Complex General Surgical Oncology at Johns Hopkins. Dr. Dal Molin received extensive postdoctoral research training at Johns Hopkins, including an NIH-funded T32 research fellowship prior to joining the surgical faculty. He specializes in the management of patients with pancreatic cancer, pancreatic cysts, as well as cancers of the liver, biliary tree and gastrointestinal tract. He is trained in traditional open and minimally invasive techniques to treating these cancers, using both laparoscopic and robotic approaches. Dr. Dal Molin’s research focuses on the development of liquid biopsies to improve the earlier detection and management of pancreatic cancer and pancreatic cysts. Another area of focus is the development of novel immunotherapies to treat pancreatic and hepatobiliary cancers.
Dr. Molin is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
His clinical research consists of co-authoring 41 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Pancreaticoduodenectomy.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
Locations
601 North Caroline Street, Floor 8, Floor 8, Baltimore, MD 21287
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Outpatient Center
Jin He, M.D., Ph.D., is a professor of surgery at the Johns Hopkins University School of Medicine and is the Division Chief of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology. Dr. He specializes in diseases and tumors of the pancreas, liver, bile duct, and gallbladder. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure. Dr. He received his medical degree from Beijing Medical University and a Ph.D. in oncology from Fudan University Shanghai Medical College. He completed the Halsted general surgery residency training at Johns Hopkins, followed by an ACGME accredited fellowship in complex general surgical oncology at Johns Hopkins. Dr. He is the John Cameron Professor of Alimentary Tract Diseases. Dr. He’s research focuses on personalized treatment through stratifying pancreatic tumors on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published extensively in peer-reviewed journals and lectured internationally. He serves on several national committees, including the NCCN panel on neuroendocrine tumors and the Alliance for Clinical Trials in Oncology. Dr. He is rated as an Elite provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy.
Johns Hopkins Outpatient Center
Christopher Shubert, M.D., M.H.A., is a general surgeon with specialty training and interests in hepato-pancreato-biliary (HPB) surgery. He is a member of the Division of Hepato-Pancreato-Biliary & Gastrointestinal Surgical Oncology at The Johns Hopkins Hospital. Dr. Shubert earned his medical degree from the University of Alabama School of Medicine and completed his general surgery residency at the Mayo Clinic in Rochester, Minnesota. He completed fellowship training in HPB surgical oncology and abdominal organ transplantation at the University of Toronto. In addition to his clinical experience, Dr. Shubert earned a Master's of Science in Healthcare Administration from the University of Alabama at Birmingham. Dr. Shubert's clinical interests include HPB surgery, resection of traditionally unresectable liver lesions, tumors involving the vena cava, and pancreas resections with vascular reconstruction. His research focus includes hepatobiliary and pancreatic malignancies, their respective treatments, perioperative management, and outcomes. Dr. Shubert is rated as an Advanced provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatic Ductal Adenocarcinoma, Pancreaticoduodenectomy, and Pancreatectomy.
Skip Viragh Outpatient Cancer Center
Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as a Distinguished provider by MediFind in Pancreaticoduodenectomy. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Pancreatic CancerDr. Molin isAdvanced. Learn about Pancreatic Cancer.
- PancreaticoduodenectomyDr. Molin isAdvanced. Learn about Pancreaticoduodenectomy.
- Experienced
- Hepato-Pancreato-Biliary SurgeryDr. Molin isExperienced. Learn about Hepato-Pancreato-Biliary Surgery.
- PancreatectomyDr. Molin isExperienced. Learn about Pancreatectomy.
- Pancreatic Ductal AdenocarcinomaDr. Molin isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.


